Female gonadal sex steroids potentiate the anti-convulsant activity of phenytoin sodium

Indian Journal of Experimental Biology

Volumn 36, Issue 7, 1998, Pages 713-715

  Kankanwadi, S K ^a,b   Patil, P A ^a  

^a JAWAHARLAL NEHRU MEDICAL COLLEGE   (India)

^b Majeedia Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYTOIN; SEX HORMONE;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; GABAERGIC TRANSMISSION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SEIZURE;

ANIMALS; ANTICONVULSANTS; DRUG EVALUATION, PRECLINICAL; DRUG SYNERGISM; ESTROGENS; FEMALE; PHENYTOIN; PROGESTERONE; RATS; RATS, WISTAR; STEROIDS;

EID: 0031826927     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Leppik J E, Recent advances in epilepsy (Churchill Livingstone, Edinburgh) 1988, 109.
2. Wolley D E & Timiras P S, Endocrinology, 70 (1962) 196.
3. Sherwin B B, J Clin Endo Metab, 72 (1991) 336.
4. Landgren S, Backstrom T & Kalistratov G, J Neurol Sci, 36 (1976) 119.
5. Blackham A & Spencer P S J, J Pharm Pharmacol, 22 (1970) 304.
6. Cynthia L W & George M S, The Pharmacological basis of therapeutics (McGraw-Hill, New York) 1996, 1433.
7. Paget G E & Barnes J M, Evaluation of drug activities: Pharmacometrics (Academic Press, London) 1964, 135.
8. Frye C A, Brain Res, 696 (1995) 113.
9. Voiculescu V, Hategan D, Manole E & Ulmeanu A, Rom J Neurol Psychiatry, 32 (1994) 131.
10. Rodriguez-Marcias K A, Gynecol-Endocrinol, 10 (1996) 139.
11. Collins P, Rosano G M C, Jiang C, Linday D, Sarrel P M & Poole-Wilson P A, Lancet, 341 (1993), 1264.
12. Hom A C, Leppik I E & Rask C A, Neurology,43 (1993) 198.